Sep 02, 2019
Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings
Aug 06, 2019
Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update
Jul 18, 2019
Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort
Jun 25, 2019
Global Angiotensin Converting Enzymes (ACE) Inhibitors Market to Surpass US$ 12.4 Billion by 2026
Jun 21, 2019
Fursultiamine (CAS 804-30-8) Market Research Report 2019 - ResearchAndMarkets.com
Jun 11, 2019
Global and China 1, 4-butanediol (BDO) Industry Report, 2019-2025 Featuring 13 Global and Chinese BDO Manufacturers - ResearchAndMarkets.com
Jun 07, 2019
PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years of Age
May 22, 2019
United States $20 Bn Breast Cancer Drug Market to 2025: 42 Marketed Drugs, 317 Drugs in Clinical Pipeline by Company, Phase, Drug Class & Patient Segment
May 07, 2019
Armas Pharmaceuticals Continues to Add to Portfolio With Launch of Second Oncology Injectable
May 02, 2019
Genital Herpes Treatment Drugs: Global Market Insights & Projections, 2016 to 2026
Apr 30, 2019
Taiwan National Health Insurance Administration of the Ministry of Health and Welfare Approves Vemlidy(R) (tenofovir alafenamide) for Reimbursement
Mar 27, 2019
Tocagen to Present Updated Data from Clinical and Preclinical Studies at Two Scientific Conferences
Feb 28, 2019
Rigel Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
Feb 20, 2019
DelMar Pharmaceuticals Achieves Halfway Enrollment Point for Phase 2 Clinical Trial of VAL-083 in Newly Diagnosed MGMT-unmethylated GBM
Feb 18, 2019
Information Update - Health Canada recommends that children and youth not use cough and cold products that contain opioids
Feb 14, 2019
Genital Herpes Market Insights, Epidemiology and Market Forecasts Report 2019 Featuring Novartis, GlaxoSmithKline, Genocea Biosciences, AiCuris & Maruho
Jan 23, 2019
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe
Jan 17, 2019
Parent Project Muscular Dystrophy Publishes 10 Year Registry Report
Jan 07, 2019
Rigel Pharmaceuticals Provides Business Update
Jan 03, 2019
Rigel to Present at the 37th Annual J.P. Morgan Healthcare Conference